Lead: In hospitals across the United States this year, a growing number of parents have declined routine preventive treatments for newborns — not only vaccines but long-established interventions such as the vitamin K injection and erythromycin eye ointment. Clinicians report that refusals have risen sharply: a national analysis of more than 5 million births found vitamin K declines rose from 2.9% in 2017 to 5.2% in 2024. Pediatricians warn that those choices, often driven by misinformation and medical mistrust, raise the risk of rare but serious outcomes including severe bleeding and blindness.
Key Takeaways
- Vitamin K refusals nearly doubled nationwide from 2.9% in 2017 to 5.2% in 2024, based on a JAMA analysis of more than 5 million births.
- Newborns who do not receive vitamin K are about 81 times more likely to develop severe vitamin K deficiency bleeding than those who do, though the condition is now rare compared with the pre-injection era.
- Before routine injections began in 1961, roughly 1 in 60 infants experienced vitamin K deficiency bleeding; that historical risk motivated the long-standing recommendation.
- Physicians in Idaho reported days when half, and other days when more than a quarter, of newborns had vitamin K withheld by parents; state pediatric leaders cited eight deaths linked to vitamin K deficiency bleeding over a recent 13-month period.
- Parents who decline vitamin K are significantly more likely to refuse other newborn protections, including the hepatitis B vaccine at birth and erythromycin eye ointment.
- Social media misinformation and broader medical mistrust are frequently cited by clinicians as drivers; some families favor “natural” approaches or fear pain and perceived side effects.
- A federal advisory committee recently voted to end the blanket recommendation for birth-dose hepatitis B immunization; a judge on Monday temporarily blocked actions taken by that reconstituted panel.
Background
Vitamin K injections, erythromycin eye ointment and the hepatitis B vaccine at birth are widely recommended preventive measures designed to avert rare but severe outcomes. Vitamin K prevents life-threatening newborn bleeding because infants are born with low stores and do not produce sufficient vitamin K in the gut until around six months of age. Erythromycin eye ointment reduces the risk of newborn eye infections from maternal gonorrhea that can lead to blindness, while hepatitis B vaccination at birth prevents chronic infection that can later cause liver failure and cancer.
The broad acceptance of these measures developed over decades after public health evidence showed dramatic reductions in preventable harms. Routine vitamin K injections began in 1961 in many settings, and immunization strategies for newborns have been refined on the basis of surveillance data. Historically, before those interventions were widespread, vitamin K deficiency bleeding affected an estimated one in 60 infants; contemporary rates are far lower but not zero for infants who miss recommended care.
Main Event
Pediatricians from Idaho to Philadelphia report a notable increase in refusals of newborn preventive care. Dr. Tom Patterson, an Idaho pediatrician, described hospital shifts in which half of the newborns he saw one day did not receive vitamin K and more than a quarter were refused on another recent day. At a February meeting of the Idaho chapter of the American Academy of Pediatrics, members reported eight deaths attributed to vitamin K deficiency bleeding over the previous 13 months, according to Patterson.
Nationwide data bolster those local reports. A study published in the Journal of the American Medical Association analyzed over 5 million births and found the rate of parental refusal of vitamin K injections rose from 2.9% in 2017 to 5.2% in 2024. Clinicians say the same families who decline vitamin K are often more likely to refuse the birth-dose hepatitis B vaccine and eye ointment, a pattern physicians see as increasing newborn vulnerability.
Doctors attribute refusals to a mix of factors: parents citing a desire for “natural” care, fear of pain or side effects, overwhelming conflicting information online, and the spread of unregulated alternatives such as oral vitamin K drops that many clinicians say are ineffective. Clinicians report daily conversations where they try to correct misconceptions — for example, explaining that vitamin K is not a vaccine — and to address parents’ specific worries.
Analysis & Implications
The trend expands a long-standing public health challenge: when distrust of medical advice grows, evidence-based preventive care can suffer. The rise in refusals of newborn interventions suggests hesitancy rooted not only in vaccine debate but in a broader skepticism toward medical recommendations. That shift has potential downstream effects, including increases in rare severe outcomes and a greater burden on neonatal intensive care and long-term developmental services for affected infants.
Clinically significant but uncommon events — severe vitamin K deficiency bleeding, neonatal blindness from gonococcal eye infection, chronic hepatitis B from perinatal transmission — are the very harms these measures prevent. Because the baseline incidence of these outcomes is low where preventive care is routine, short-term changes in rates can be hard to detect without large datasets; but the JAMA analysis and state-level reports indicate measurable increases in refusal behavior that could presage more preventable illness.
Policy debates also affect practice. A federal advisory committee, reconstituted under the current Health Secretary, voted to remove the longstanding universal recommendation for the hepatitis B birth dose — a move that a federal judge temporarily blocked on Monday. Even the appearance of shifting policy guidance can amplify parental uncertainty and complicate clinicians’ conversations with families.
Comparison & Data
| Measure | Historical/2017 | 2024 |
|---|---|---|
| Vitamin K refusal rate (national) | 2.9% (2017) | 5.2% (2024) |
| Relative risk of severe bleeding without vitamin K | Baseline era: ≈1 in 60 infants affected | Non-vaccinated newborns ~81× higher risk of severe bleeding |
The table summarizes key figures from the national analysis and historical estimates. While absolute numbers of severe outcomes remain low compared with the pre-intervention era, the relative increase in parental refusal rates can translate to additional cases because the prevented harms are rare but severe. Public health surveillance and hospital reporting will be essential to monitor whether short-term rises in refusals become sustained trends.
Reactions & Quotes
“When you look at a child who’s innocent and vulnerable — and a simple intervention that’s been done since 1961 is refused — knowing that baby’s going out into the world is super worrisome to me.”
Dr. Tom Patterson, Idaho pediatrician
Patterson frames refusals as an urgent clinical worry, citing both his day-to-day hospital experience and state-level reports of fatal cases. He emphasizes clinicians’ emotional burden when preventable harms occur.
“I do think these families care deeply about their infants, but they are hearing conflicting information.”
Dr. Kelly Wade, neonatologist, Philadelphia
Dr. Wade highlights the information environment: clinicians say social media and assorted nonprofessional voices are a major source of confusion for new parents, complicating shared decision-making during short postpartum hospital stays.
“Nature will allow 1 in 5 human infants to die in the first year of life, which is why generations of scientists and doctors have worked to bring that number way, way down.”
Dr. David Hill, pediatrician and researcher, Seattle
Dr. Hill uses historical perspective to argue that many modern preventive steps substantially reduced child mortality; he urges respectful, evidence-based dialogue to restore trust with families.
Unconfirmed
- The precise causal impact of social media posts on individual parental decisions is reported by clinicians but not quantified here; formal studies linking specific online narratives to refusal rates remain limited.
- Claims about the effectiveness of unregulated oral vitamin K supplements vary; some clinicians say these formulations are poorly absorbed, but large comparative trials are scarce.
- Reported counts of deaths attributed to vitamin K deficiency (for example, eight deaths cited by Idaho pediatricians over 13 months) are clinician reports that would benefit from independent public health verification.
Bottom Line
Doctors and public-health experts view the expansion of refusal behavior beyond vaccines to other newborn preventive measures as a significant, solvable problem. The evidence shows measurable increases in parental refusals and well-established risks to infants who miss vitamin K, eye prophylaxis and the hepatitis B birth dose. Because these interventions prevent rare but severe outcomes, even modest rises in refusal rates can lead to additional preventable illness and death.
Clinicians emphasize that respectful, patient-centered conversations are central to reversing the trend: listening to parental concerns, correcting specific misconceptions, and explaining the clear evidence of benefit. Public-health agencies, hospitals and professional societies will need to maintain surveillance, communicate consistently, and invest in outreach that addresses misinformation while respecting families’ values.
Sources
- CNN (news report summarizing clinician interviews and national context)
- Journal of the American Medical Association (JAMA) (academic journal — national study of >5 million births reporting refusal rates)